Testing effectiveness (Phase 2)Study completedNCT01107457What this trial is testingA Study in Participants With Moderate to Severe PsoriasisWho this might be right forPsoriasis Eli Lilly and Company 142
Not applicableStudy completedNCT06209463What this trial is testingPosture, Hand Functions and Sensory Processing Skills on NutritionWho this might be right forAutism Spectrum DisorderAutismAutism, Mild+1 more Bezmialem Vakif University 80
Testing effectiveness (Phase 2)UnknownNCT04379167What this trial is testingClinical Study of YY-20394 in Patients With Relapsed/Refractory Follicular LymphomaWho this might be right forFollicular Lymphoma Shanghai YingLi Pharmaceutical Co. Ltd. 140
Testing effectiveness (Phase 2)Study completedNCT01359592What this trial is testingS1001 PET-Directed Therapy in Treating Patients With Limited-Stage Diffuse Large B-Cell LymphomaWho this might be right forLymphoma SWOG Cancer Research Network 159
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06684509What this trial is testingAtorvaststin and Cardiotoxicity in Acute Myloid LeukemiaWho this might be right forLeukemiaHodgkin Disease Assiut University 46
Testing effectiveness (Phase 2)UnknownNCT05631912What this trial is testingTRAC Locus-inserted CD19-targeting STAR-T Cell Therapy in r/r B-NHLWho this might be right forNon-hodgkin Lymphoma,B Cell Chinese PLA General Hospital 38
Not applicableStudy completedNCT02106611What this trial is testingTissue and Functional Assessment of Myocardial Injury in Hodgkin Lymphoma (HL) SurvivorsWho this might be right forHodgkin Lymphoma Survivor Memorial Sloan Kettering Cancer Center 133
Large-scale testing (Phase 3)Study completedNCT01144364What this trial is testingMabThera (Rituximab) in Elderly Patients With Untreated Follicular Non-Hodgkin's Lymphoma (NHL)Who this might be right forNon-Hodgkin's Lymphoma Hoffmann-La Roche 234
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07313852What this trial is testingInotuzumab and Blinatumomab in People With B-cell Acute Lymphoblastic LeukemiaWho this might be right forB-cell Acute Lymphoblastic LeukemiaB-Cell Acute Lymphoblastic Leukemia, AdultB-ALL Memorial Sloan Kettering Cancer Center 26
Testing effectiveness (Phase 2)Study completedNCT03200015What this trial is testingRituximab, Cyclophosphamide, Vincristine and Prednisone (R-CHOP) Plus Metformin in Diffuse Large-B-cell LymphomaWho this might be right forDiffuse Large B Cell Lymphoma Hospital Universitario Dr. Jose E. Gonzalez 15
Early research (Phase 1)Study completedNCT00003289What this trial is testingUCN-01 in Treating Patients With Advanced CancerWho this might be right forLeukemiaLymphomaUnspecified Adult Solid Tumor, Protocol Specific Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Early research (Phase 1)Study completedNCT01606878What this trial is testingCrizotinib and Combination Chemotherapy in Treating Younger Patients With Relapsed or Refractory Solid Tumors or Anaplastic Large Cell LymphomaWho this might be right forChildhood Solid NeoplasmRecurrent Childhood Anaplastic Large Cell LymphomaRecurrent Neuroblastoma Children's Oncology Group 46
Very early researchEnded earlyNCT01878708What this trial is testingA Pilot Study of Oncaspar® + Dexamethasone in Patients With Relapsed or Refractory T-Cell LymphomaWho this might be right forT-Cell LymphomaRelapsed T-Cell LymphomaRefractory T-Cell Lymphoma Dana-Farber Cancer Institute 2
Not applicableStudy completedNCT00165308What this trial is testingTamoxifen in the Prevention of Breast Cancer in Hodgkin's Disease SurvivorsWho this might be right forHodgkin's DiseaseBreast Cancer Dana-Farber Cancer Institute 29
Not applicableStudy completedNCT06610617What this trial is testingNeuromodulation of Central Sensory Integration to Improve Postural ControlWho this might be right forSurvivorshipQuality of LifeCognitive Deficits, Mild University of Pittsburgh 48
Testing effectiveness (Phase 2)Looking for participantsNCT06530550What this trial is testingPI3K Inhibitors for the Treatment of Relapsed/Refractory Indolent T/NK-cell LymphomasWho this might be right forLymphoma, T-CellNK-LGL LeukemiaT-LGL Leukemia Institute of Hematology & Blood Diseases Hospital, China 51
Testing effectiveness (Phase 2)Study completedNCT02362035What this trial is testingACP-196 (Acalabrutinib) in Combination With Pembrolizumab, for Treatment of Hematologic MalignanciesWho this might be right forFollicular Lymphoma (FL)CLLSmall Lymphocytic Lymphoma (SLL)+10 more Acerta Pharma BV 161
Testing effectiveness (Phase 2)Looking for participantsNCT04792489What this trial is testingDALY II USA/ MB-CART2019.1 for DLBCLWho this might be right forRefractory Diffuse Large B Cell Lymphoma (DLBCL)Relapsed Diffuse Large B Cell LymphomaHigh Grade B-cell Lymphoma (HGBCL)+6 more Miltenyi Biomedicine GmbH 315
Not applicableStudy completedNCT01266668What this trial is testingThe Impact of Rituximab in Patients With Primary Breast Diffuse Large B Cell Lymphoma (DLBCL)Who this might be right forLymphoma, Large B-Cell, Diffuse Chonbuk National University Hospital 100
Not applicableStudy completedNCT04858568What this trial is testingImmune Responses to COVID-19 Vaccination in Lymphoma PatientsWho this might be right forClassical Hodgkin LymphomaDiffuse Large B Cell LymphomaPrimary Mediastinal B Cell Lymphoma+10 more University Hospital Southampton NHS Foundation Trust 592